Chuck Royce's ZVRA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 988,674 shares of Zevra Therapeutics, Inc. (ZVRA) worth $9.21 M, representing 0.09% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Chuck Royce has maintained this position in ZVRA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 174,583 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Zevra Therapeutics (ZVRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zevra Therapeutics (ZVRA) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +122,852 | Add 14.19% | 988,674 | $9.32 |
| Q4 2025 | +174,583 | Add 25.26% | 865,822 | $8.96 |
| Q3 2025 | +691,239 | New Buy | 691,239 | $9.51 |
Chuck Royce's Zevra Therapeutics Investment FAQs
Chuck Royce first purchased Zevra Therapeutics, Inc. (ZVRA) in Q3 2025, acquiring 691,239 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Zevra Therapeutics, Inc. (ZVRA) for 3 quarters since Q3 2025.
Chuck Royce's largest addition to Zevra Therapeutics, Inc. (ZVRA) was in Q3 2025, adding 691,239 shares worth $6.57 M.
According to the latest 13F filing for Q1 2026, Chuck Royce's firm, Royce & Associates Lp, owns 988,674 shares of Zevra Therapeutics, Inc. (ZVRA), valued at approximately $9.21 M.
As of the Q1 2026 filing, Zevra Therapeutics, Inc. (ZVRA) represents approximately 0.09% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Zevra Therapeutics, Inc. (ZVRA) was 988,674 shares, as reported at the end of Q1 2026.